Logo image of IBTA

IBOTTA INC-CL A (IBTA) Stock Fundamental Analysis

NYSE:IBTA - New York Stock Exchange, Inc. - US4510511060 - Common Stock - Currency: USD

38.28  -1.78 (-4.44%)

After market: 38.5 +0.22 (+0.57%)

Fundamental Rating

5

Taking everything into account, IBTA scores 5 out of 10 in our fundamental rating. IBTA was compared to 97 industry peers in the Media industry. While IBTA has a great health rating, its profitability is only average at the moment. IBTA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year IBTA has reported negative net income.
IBTA had a positive operating cash flow in the past year.
IBTA Yearly Net Income VS EBIT VS OCF VS FCFIBTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

IBTA has a Return On Assets of 9.39%. This is amongst the best in the industry. IBTA outperforms 91.75% of its industry peers.
IBTA has a better Return On Equity (14.95%) than 80.41% of its industry peers.
IBTA has a Return On Invested Capital (2.11%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 9.39%
ROE 14.95%
ROIC 2.11%
ROA(3y)-2.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBTA Yearly ROA, ROE, ROICIBTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 50 -50 100 150

1.3 Margins

IBTA has a Profit Margin of 16.24%. This is amongst the best in the industry. IBTA outperforms 92.78% of its industry peers.
The Operating Margin of IBTA (2.93%) is comparable to the rest of the industry.
IBTA has a Gross Margin of 84.66%. This is amongst the best in the industry. IBTA outperforms 95.88% of its industry peers.
Industry RankSector Rank
OM 2.93%
PM (TTM) 16.24%
GM 84.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IBTA Yearly Profit, Operating, Gross MarginsIBTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBTA is destroying value.
IBTA has more shares outstanding than it did 1 year ago.
IBTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IBTA Yearly Shares OutstandingIBTA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
IBTA Yearly Total Debt VS Total AssetsIBTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M

2.2 Solvency

IBTA has an Altman-Z score of 3.82. This indicates that IBTA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.82, IBTA belongs to the top of the industry, outperforming 83.51% of the companies in the same industry.
IBTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.82
ROIC/WACC0.24
WACC8.98%
IBTA Yearly LT Debt VS Equity VS FCFIBTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

IBTA has a Current Ratio of 2.69. This indicates that IBTA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.69, IBTA belongs to the top of the industry, outperforming 85.57% of the companies in the same industry.
IBTA has a Quick Ratio of 2.69. This indicates that IBTA is financially healthy and has no problem in meeting its short term obligations.
IBTA has a better Quick ratio (2.69) than 85.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 2.69
IBTA Yearly Current Assets VS Current LiabilitesIBTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.05% over the past year.
The Revenue has grown by 14.75% in the past year. This is quite good.
EPS 1Y (TTM)103.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.82%
Revenue 1Y (TTM)14.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.73%

3.2 Future

IBTA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 141.18% yearly.
Based on estimates for the next years, IBTA will show a quite strong growth in Revenue. The Revenue will grow by 11.87% on average per year.
EPS Next Y471.2%
EPS Next 2Y224.02%
EPS Next 3Y141.18%
EPS Next 5YN/A
Revenue Next Year3.32%
Revenue Next 2Y9.27%
Revenue Next 3Y11.87%
Revenue Next 5YN/A

3.3 Evolution

IBTA Yearly Revenue VS EstimatesIBTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
IBTA Yearly EPS VS EstimatesIBTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5 2 2.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

IBTA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 19.19, IBTA is valued on the expensive side.
Based on the Price/Forward Earnings ratio, IBTA is valued a bit cheaper than the industry average as 61.86% of the companies are valued more expensively.
IBTA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 37.78.
Industry RankSector Rank
PE N/A
Fwd PE 19.19
IBTA Price Earnings VS Forward Price EarningsIBTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IBTA indicates a slightly more expensive valuation: IBTA is more expensive than 65.98% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, IBTA is valued a bit cheaper than 78.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.5
EV/EBITDA 43.99
IBTA Per share dataIBTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IBTA's earnings are expected to grow with 141.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y224.02%
EPS Next 3Y141.18%

More info and screens

0

5. Dividend

5.1 Amount

IBTA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IBOTTA INC-CL A

NYSE:IBTA (7/28/2025, 8:04:01 PM)

After market: 38.5 +0.22 (+0.57%)

38.28

-1.78 (-4.44%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-13 2025-08-13
Inst Owners51.8%
Inst Owner Change0.05%
Ins Owners7.26%
Ins Owner Change-0.01%
Market Cap1.09B
Analysts76
Price Target60.82 (58.88%)
Short Float %11.66%
Short Ratio4.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)179.21%
Min EPS beat(2)46.79%
Max EPS beat(2)311.64%
EPS beat(4)3
Avg EPS beat(4)87.04%
Min EPS beat(4)-52.55%
Max EPS beat(4)311.64%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.94%
Min Revenue beat(2)-6.93%
Max Revenue beat(2)1.04%
Revenue beat(4)3
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-6.93%
Max Revenue beat(4)2.8%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.45%
PT rev (3m)7.67%
EPS NQ rev (1m)-3.57%
EPS NQ rev (3m)-24.86%
EPS NY rev (1m)0%
EPS NY rev (3m)-29.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.19
P/S 2.95
P/FCF 10.5
P/OCF 9.36
P/B 2.71
P/tB 2.71
EV/EBITDA 43.99
EPS(TTM)-0.08
EYN/A
EPS(NY)1.99
Fwd EY5.21%
FCF(TTM)3.65
FCFY9.52%
OCF(TTM)4.09
OCFY10.69%
SpS12.99
BVpS14.1
TBVpS14.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.39%
ROE 14.95%
ROCE 2.44%
ROIC 2.11%
ROICexc 6.43%
ROICexgc 6.43%
OM 2.93%
PM (TTM) 16.24%
GM 84.66%
FCFM 28.07%
ROA(3y)-2.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 152.38%
Cap/Sales 3.44%
Interest Coverage 250
Cash Conversion 607.79%
Profit Quality 172.85%
Current Ratio 2.69
Quick Ratio 2.69
Altman-Z 3.82
F-Score5
WACC8.98%
ROIC/WACC0.24
Cap/Depr(3y)126.83%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.82%
EPS Next Y471.2%
EPS Next 2Y224.02%
EPS Next 3Y141.18%
EPS Next 5YN/A
Revenue 1Y (TTM)14.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.73%
Revenue Next Year3.32%
Revenue Next 2Y9.27%
Revenue Next 3Y11.87%
Revenue Next 5YN/A
EBIT growth 1Y-50.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year213.61%
EBIT Next 3Y75.4%
EBIT Next 5YN/A
FCF growth 1Y629.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y410.29%
OCF growth 3YN/A
OCF growth 5YN/A